More progress made towards the start of Phase III, we have now made it on to the clinicltrials.gov and there is lots of good information about the trial included there.
In particular I would draw your attention to the following
Estimated start date : June 2022
Estimated primary completion date: March 2023
Estimated study completion date: July 2023
https://www.clinicaltrials.gov/ct2/show/NCT05347147?term=invex&draw=2&rank=1
More progress made towards the start of Phase III, we have now...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.411M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 158 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.12pm 29/07/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable